Our previous studies have shown that neonatal delivery of angiotensin type
1 receptor antisense (AT(1)R-AS) in a retroviral vector prevents spontaneou
sly hypertensive rats from developing hypertension for life but has no effe
ct on blood pressure (BP) in normotensive animals. Based on these results,
we hypothesized that AT(1)R-AS transduction in normotensive rats would prot
ect them from developing experimental hypertension. The present study was d
esigned to evaluate this hypothesis. A single intracardiac administration o
f AT(1)R-AS by a retroviral-mediated delivery system (LNSV-AT(1)R-AS) in 5-
day-old normotensive Sprague-Dawley rats resulted in long-term expression o
f the AT(1)R-AS without an effect on basal BP. However, angiotensin II (Ang
II)-induced BP, dipsogenic responses, and renovascular contractility were
significantly attenuated in the LNSV-AT(1)R-AS-treated rats. Chronic infusi
on of low-dose Ang II (55 ng . kg(-1) . min(-1)) in LNSV-alone-treated rats
caused a modest increase in BP, profound increase in cardiac hypertrophy,
and increased vascular contractility. In contrast, the LNSV-AT(1)R-AS-treat
ed rats were protected from developing these changes after Ang II infusion.
These data establish that LNSV-AT(1)R-AS pretreatment protects healthy rat
s from developing Ang II-dependent hypertension.